

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 9.78539747 |
| 2 | ATP synthesis coupled proton transport (GO:0015986) | 9.78539747 |
| 3 | * mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 9.11669499 |
| 4 | * respiratory electron transport chain (GO:0022904) | 8.49905747 |
| 5 | * electron transport chain (GO:0022900) | 8.28137755 |
| 6 | chaperone-mediated protein transport (GO:0072321) | 5.92479564 |
| 7 | protein complex biogenesis (GO:0070271) | 5.55664188 |
| 8 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 5.41835230 |
| 9 | NADH dehydrogenase complex assembly (GO:0010257) | 5.41835230 |
| 10 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 5.41835230 |
| 11 | ATP biosynthetic process (GO:0006754) | 5.33517957 |
| 12 | protein neddylation (GO:0045116) | 5.25407014 |
| 13 | hydrogen ion transmembrane transport (GO:1902600) | 5.24669525 |
| 14 | inner mitochondrial membrane organization (GO:0007007) | 5.03733641 |
| 15 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 5.03319665 |
| 16 | mitochondrial respiratory chain complex assembly (GO:0033108) | 5.01892868 |
| 17 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 4.97334816 |
| 18 | oxidative phosphorylation (GO:0006119) | 4.89234253 |
| 19 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.89222032 |
| 20 | proton transport (GO:0015992) | 4.65656938 |
| 21 | hydrogen transport (GO:0006818) | 4.57948487 |
| 22 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 4.37750444 |
| 23 | GTP biosynthetic process (GO:0006183) | 3.97625644 |
| 24 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.90346129 |
| 25 | melanin biosynthetic process (GO:0042438) | 3.89221391 |
| 26 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.76070843 |
| 27 | axon ensheathment in central nervous system (GO:0032291) | 3.75351449 |
| 28 | central nervous system myelination (GO:0022010) | 3.75351449 |
| 29 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.71849282 |
| 30 | secondary metabolite biosynthetic process (GO:0044550) | 3.70812658 |
| 31 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.69413024 |
| 32 | aerobic respiration (GO:0009060) | 3.63757640 |
| 33 | regulation of mitochondrial translation (GO:0070129) | 3.61358237 |
| 34 | protein targeting to mitochondrion (GO:0006626) | 3.59801374 |
| 35 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.57881903 |
| 36 | negative regulation of ligase activity (GO:0051352) | 3.57881903 |
| 37 | respiratory chain complex IV assembly (GO:0008535) | 3.56682417 |
| 38 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.51855753 |
| 39 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.51855753 |
| 40 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.51842515 |
| 41 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.48860898 |
| 42 | mitochondrial transport (GO:0006839) | 3.48438424 |
| 43 | viral transcription (GO:0019083) | 3.47452216 |
| 44 | establishment of protein localization to mitochondrion (GO:0072655) | 3.47356649 |
| 45 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.40877135 |
| 46 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.40877135 |
| 47 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.40654393 |
| 48 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.40654393 |
| 49 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.40654393 |
| 50 | fatty acid elongation (GO:0030497) | 3.40228298 |
| 51 | cotranslational protein targeting to membrane (GO:0006613) | 3.38879549 |
| 52 | protein localization to mitochondrion (GO:0070585) | 3.38422833 |
| 53 | substantia nigra development (GO:0021762) | 3.31786279 |
| 54 | termination of RNA polymerase III transcription (GO:0006386) | 3.31613013 |
| 55 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.31613013 |
| 56 | translational termination (GO:0006415) | 3.30326228 |
| 57 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.29874467 |
| 58 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.29874467 |
| 59 | regulation of oxidative phosphorylation (GO:0002082) | 3.29648904 |
| 60 | ribosomal small subunit biogenesis (GO:0042274) | 3.29451455 |
| 61 | protein targeting to ER (GO:0045047) | 3.29430898 |
| 62 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.27832377 |
| 63 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.27832377 |
| 64 | melanin metabolic process (GO:0006582) | 3.27296699 |
| 65 | cytochrome complex assembly (GO:0017004) | 3.26990019 |
| 66 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.26163791 |
| 67 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.26073824 |
| 68 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.25019759 |
| 69 | UTP biosynthetic process (GO:0006228) | 3.23420134 |
| 70 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.23285504 |
| 71 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.20884356 |
| 72 | protein localization to endoplasmic reticulum (GO:0070972) | 3.19267261 |
| 73 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.15439609 |
| 74 | regulation of cellular respiration (GO:0043457) | 3.10802188 |
| 75 | * generation of precursor metabolites and energy (GO:0006091) | 3.07963407 |
| 76 | tricarboxylic acid cycle (GO:0006099) | 3.07610065 |
| 77 | intracellular protein transmembrane import (GO:0044743) | 3.07602252 |
| 78 | rRNA modification (GO:0000154) | 3.04736857 |
| 79 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.04215437 |
| 80 | positive regulation of ligase activity (GO:0051351) | 3.03398136 |
| 81 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.01543390 |
| 82 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.01543390 |
| 83 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.99722644 |
| 84 | regulation of cellular amine metabolic process (GO:0033238) | 2.96708537 |
| 85 | proteasome assembly (GO:0043248) | 2.95900658 |
| 86 | protein maturation by protein folding (GO:0022417) | 2.94886543 |
| 87 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.93402202 |
| 88 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.92568537 |
| 89 | cellular component biogenesis (GO:0044085) | 2.91140511 |
| 90 | UTP metabolic process (GO:0046051) | 2.90192367 |
| 91 | peptidyl-histidine modification (GO:0018202) | 2.88538327 |
| 92 | cellular respiration (GO:0045333) | 2.88314270 |
| 93 | ribosomal large subunit biogenesis (GO:0042273) | 2.88172601 |
| 94 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.87976712 |
| 95 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.86705742 |
| 96 | CENP-A containing nucleosome assembly (GO:0034080) | 2.85725883 |
| 97 | chromatin remodeling at centromere (GO:0031055) | 2.85239826 |
| 98 | pseudouridine synthesis (GO:0001522) | 2.84630855 |
| 99 | positive regulation of action potential (GO:0045760) | 2.81739475 |
| 100 | dopamine transport (GO:0015872) | 2.80848239 |
| 101 | spliceosomal snRNP assembly (GO:0000387) | 2.78925028 |
| 102 | purine ribonucleoside biosynthetic process (GO:0046129) | 2.78446937 |
| 103 | purine nucleoside biosynthetic process (GO:0042451) | 2.78446937 |
| 104 | C-terminal protein lipidation (GO:0006501) | 2.78335987 |
| 105 | cellular protein complex disassembly (GO:0043624) | 2.77827521 |
| 106 | translational elongation (GO:0006414) | 2.77784949 |
| 107 | ubiquinone biosynthetic process (GO:0006744) | 2.76874771 |
| 108 | quinone biosynthetic process (GO:1901663) | 2.76874771 |
| 109 | platelet dense granule organization (GO:0060155) | 2.76584462 |
| 110 | regulation of ligase activity (GO:0051340) | 2.74642995 |
| 111 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.73364286 |
| 112 | succinate metabolic process (GO:0006105) | 2.73182155 |
| 113 | viral life cycle (GO:0019058) | 2.72191546 |
| 114 | translation (GO:0006412) | 2.72179035 |
| 115 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.71778202 |
| 116 | branched-chain amino acid catabolic process (GO:0009083) | 2.69307114 |
| 117 | ribosomal small subunit assembly (GO:0000028) | 2.69041414 |
| 118 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.68454325 |
| 119 | protein-cofactor linkage (GO:0018065) | 2.68019615 |
| 120 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.67562120 |
| 121 | cullin deneddylation (GO:0010388) | 2.67500686 |
| 122 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.65470698 |
| 123 | ubiquinone metabolic process (GO:0006743) | 2.65077329 |
| 124 | establishment of integrated proviral latency (GO:0075713) | 2.62348428 |
| 125 | CTP biosynthetic process (GO:0006241) | 2.59502050 |
| 126 | CTP metabolic process (GO:0046036) | 2.59502050 |
| 127 | neurotransmitter uptake (GO:0001504) | 2.58329466 |
| 128 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.56718493 |
| 129 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.54694752 |
| 130 | mitochondrion morphogenesis (GO:0070584) | 2.52723831 |
| 131 | detection of temperature stimulus (GO:0016048) | 2.50111369 |
| 132 | neuron cell-cell adhesion (GO:0007158) | 2.49533010 |
| 133 | establishment of viral latency (GO:0019043) | 2.47535033 |
| 134 | positive regulation of mitochondrial fission (GO:0090141) | 2.47444050 |
| 135 | cholesterol biosynthetic process (GO:0006695) | 2.44606677 |
| 136 | mannosylation (GO:0097502) | 2.43899679 |
| 137 | neuronal action potential propagation (GO:0019227) | 2.43515669 |
| 138 | aldehyde catabolic process (GO:0046185) | 2.41950461 |
| 139 | aggressive behavior (GO:0002118) | 2.41928577 |
| 140 | intracellular protein transmembrane transport (GO:0065002) | 2.41101028 |
| 141 | NADH metabolic process (GO:0006734) | 2.40741291 |
| 142 | ribonucleoside monophosphate biosynthetic process (GO:0009156) | 2.36935917 |
| 143 | protein deneddylation (GO:0000338) | 2.35926334 |
| 144 | ribonucleoside biosynthetic process (GO:0042455) | 2.33258225 |
| 145 | protein localization to cilium (GO:0061512) | 2.32696026 |
| 146 | neural nucleus development (GO:0048857) | 2.29719818 |
| 147 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 10.2518421 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.02271167 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.69558083 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.22520995 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.21496412 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.93961781 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.84556570 |
| 7 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.67792950 |
| 8 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.66803924 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.52075444 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.47822274 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.38077945 |
| 12 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.37841055 |
| 13 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.32947464 |
| 14 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.29017253 |
| 15 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.28971134 |
| 16 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.28260386 |
| 17 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.28185837 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.24102734 |
| 19 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.22838841 |
| 20 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 2.18159308 |
| 21 | * GABP_19822575_ChIP-Seq_HepG2_Human | 2.17661399 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.16844366 |
| 23 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.15252609 |
| 24 | VDR_22108803_ChIP-Seq_LS180_Human | 2.10168829 |
| 25 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.07344047 |
| 26 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.03988669 |
| 27 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.00729033 |
| 28 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.95000597 |
| 29 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.94537341 |
| 30 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.91849659 |
| 31 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.91240356 |
| 32 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.88869872 |
| 33 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.84729562 |
| 34 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.83684496 |
| 35 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.81164695 |
| 36 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.79824278 |
| 37 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.77216231 |
| 38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.76325519 |
| 39 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.71936308 |
| 40 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.70776559 |
| 41 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.69601111 |
| 42 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.67094587 |
| 43 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.66485620 |
| 44 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.64263063 |
| 45 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.63536763 |
| 46 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.62067604 |
| 47 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.60254698 |
| 48 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.56143977 |
| 49 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.55747435 |
| 50 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.54971166 |
| 51 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.53323366 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.52832284 |
| 53 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.51701483 |
| 54 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.51579208 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.45423089 |
| 56 | FUS_26573619_Chip-Seq_HEK293_Human | 1.45196292 |
| 57 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.44732487 |
| 58 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41713254 |
| 59 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.40878833 |
| 60 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.40188803 |
| 61 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.39849700 |
| 62 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.38188438 |
| 63 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.36565473 |
| 64 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.36565473 |
| 65 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.33725730 |
| 66 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.33187668 |
| 67 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.32987121 |
| 68 | P300_19829295_ChIP-Seq_ESCs_Human | 1.32608503 |
| 69 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.31781675 |
| 70 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.28518155 |
| 71 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.27581705 |
| 72 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.27046549 |
| 73 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.26952859 |
| 74 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.26011111 |
| 75 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.25121798 |
| 76 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.24965093 |
| 77 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.21898908 |
| 78 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.20410465 |
| 79 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18865269 |
| 80 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.18276245 |
| 81 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.17248218 |
| 82 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.16459943 |
| 83 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.16107783 |
| 84 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.14501945 |
| 85 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13588878 |
| 86 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.13389900 |
| 87 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.12461647 |
| 88 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.12433985 |
| 89 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.12286316 |
| 90 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.11740600 |
| 91 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.11727187 |
| 92 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11631576 |
| 93 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.10961602 |
| 94 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.10299614 |
| 95 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.10056013 |
| 96 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.09253570 |
| 97 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08707928 |
| 98 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.06193984 |
| 99 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.05574104 |
| 100 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.04737980 |
| 101 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.04654071 |
| 102 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.04593434 |
| 103 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.02765452 |
| 104 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.99719269 |
| 105 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.99215579 |
| 106 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.98807649 |
| 107 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.97658543 |
| 108 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.97538727 |
| 109 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96668017 |
| 110 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96211937 |
| 111 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.95898198 |
| 112 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.95658376 |
| 113 | JUN_21703547_ChIP-Seq_K562_Human | 0.94709637 |
| 114 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.94203500 |
| 115 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.93168148 |
| 116 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.92877864 |
| 117 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.92621087 |
| 118 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92383687 |
| 119 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.91651761 |
| 120 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.91600388 |
| 121 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.91378788 |
| 122 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.91095239 |
| 123 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.90154821 |
| 124 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.87984801 |
| 125 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.87984801 |
| 126 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.87881820 |
| 127 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.87373290 |
| 128 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.86644562 |
| 129 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.86430559 |
| 130 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.86174915 |
| 131 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.86105951 |
| 132 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.85727339 |
| 133 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.85099768 |
| 134 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.84073754 |
| 135 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.84041971 |
| 136 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.83613528 |
| 137 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.83418575 |
| 138 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.82116721 |
| 139 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.81483724 |
| 140 | * NCOR_22424771_ChIP-Seq_293T_Human | 0.81313919 |
| 141 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.81220324 |
| 142 | EWS_26573619_Chip-Seq_HEK293_Human | 0.80813940 |
| 143 | AR_20517297_ChIP-Seq_VCAP_Human | 0.79963458 |
| 144 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79871650 |
| 145 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76752009 |
| 146 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.75817962 |
| 147 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.75817962 |
| 148 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.75801654 |
| 149 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.75128320 |
| 150 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.74599866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.06947773 |
| 2 | MP0001529_abnormal_vocalization | 3.86013313 |
| 3 | MP0009379_abnormal_foot_pigmentation | 3.69000448 |
| 4 | MP0002736_abnormal_nociception_after | 3.53265649 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.03465556 |
| 6 | MP0006276_abnormal_autonomic_nervous | 2.93453887 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 2.86937885 |
| 8 | MP0006036_abnormal_mitochondrial_physio | 2.53524225 |
| 9 | MP0005075_abnormal_melanosome_morpholog | 2.40995296 |
| 10 | MP0001905_abnormal_dopamine_level | 2.38807760 |
| 11 | MP0002735_abnormal_chemical_nociception | 2.29454462 |
| 12 | MP0002102_abnormal_ear_morphology | 2.26756594 |
| 13 | MP0002938_white_spotting | 2.24296868 |
| 14 | MP0008058_abnormal_DNA_repair | 2.23632542 |
| 15 | MP0002272_abnormal_nervous_system | 2.16149133 |
| 16 | MP0004142_abnormal_muscle_tone | 2.15062729 |
| 17 | MP0002734_abnormal_mechanical_nocicepti | 2.07295467 |
| 18 | MP0004270_analgesia | 2.06565039 |
| 19 | MP0002064_seizures | 2.04578467 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.01709950 |
| 21 | MP0001970_abnormal_pain_threshold | 1.97611436 |
| 22 | MP0002733_abnormal_thermal_nociception | 1.96448194 |
| 23 | MP0009745_abnormal_behavioral_response | 1.92625562 |
| 24 | MP0002638_abnormal_pupillary_reflex | 1.92557339 |
| 25 | MP0010094_abnormal_chromosome_stability | 1.85765268 |
| 26 | MP0002095_abnormal_skin_pigmentation | 1.82903047 |
| 27 | MP0006035_abnormal_mitochondrial_morpho | 1.81956384 |
| 28 | MP0003718_maternal_effect | 1.80852988 |
| 29 | MP0009046_muscle_twitch | 1.79768644 |
| 30 | MP0003693_abnormal_embryo_hatching | 1.78145810 |
| 31 | MP0000751_myopathy | 1.77883526 |
| 32 | MP0003123_paternal_imprinting | 1.75659914 |
| 33 | MP0000015_abnormal_ear_pigmentation | 1.70370571 |
| 34 | MP0003635_abnormal_synaptic_transmissio | 1.69796932 |
| 35 | MP0001486_abnormal_startle_reflex | 1.68012367 |
| 36 | MP0005423_abnormal_somatic_nervous | 1.67354057 |
| 37 | MP0004215_abnormal_myocardial_fiber | 1.64670513 |
| 38 | MP0002876_abnormal_thyroid_physiology | 1.60321067 |
| 39 | MP0004043_abnormal_pH_regulation | 1.59522470 |
| 40 | MP0002572_abnormal_emotion/affect_behav | 1.58861797 |
| 41 | MP0003646_muscle_fatigue | 1.58716369 |
| 42 | MP0002067_abnormal_sensory_capabilities | 1.57954527 |
| 43 | MP0004957_abnormal_blastocyst_morpholog | 1.57424188 |
| 44 | MP0005645_abnormal_hypothalamus_physiol | 1.53076886 |
| 45 | MP0005386_behavior/neurological_phenoty | 1.52024017 |
| 46 | MP0004924_abnormal_behavior | 1.52024017 |
| 47 | MP0000920_abnormal_myelination | 1.51221559 |
| 48 | MP0008875_abnormal_xenobiotic_pharmacok | 1.50362777 |
| 49 | MP0004036_abnormal_muscle_relaxation | 1.49661894 |
| 50 | MP0003786_premature_aging | 1.47225868 |
| 51 | MP0001764_abnormal_homeostasis | 1.47143031 |
| 52 | MP0004742_abnormal_vestibular_system | 1.43234474 |
| 53 | MP0005171_absent_coat_pigmentation | 1.42559319 |
| 54 | MP0000749_muscle_degeneration | 1.40953778 |
| 55 | MP0001984_abnormal_olfaction | 1.40665975 |
| 56 | MP0004859_abnormal_synaptic_plasticity | 1.40368400 |
| 57 | MP0010386_abnormal_urinary_bladder | 1.39899365 |
| 58 | MP0006072_abnormal_retinal_apoptosis | 1.39531830 |
| 59 | MP0001485_abnormal_pinna_reflex | 1.38538153 |
| 60 | MP0003806_abnormal_nucleotide_metabolis | 1.34892626 |
| 61 | MP0003136_yellow_coat_color | 1.34156107 |
| 62 | MP0003195_calcinosis | 1.33346115 |
| 63 | MP0004145_abnormal_muscle_electrophysio | 1.31151640 |
| 64 | MP0001986_abnormal_taste_sensitivity | 1.30915952 |
| 65 | MP0008932_abnormal_embryonic_tissue | 1.30466864 |
| 66 | MP0002063_abnormal_learning/memory/cond | 1.29996944 |
| 67 | MP0001324_abnormal_eye_pigmentation | 1.28348385 |
| 68 | MP0005379_endocrine/exocrine_gland_phen | 1.27082821 |
| 69 | MP0002160_abnormal_reproductive_system | 1.26391416 |
| 70 | MP0001501_abnormal_sleep_pattern | 1.25861034 |
| 71 | MP0003011_delayed_dark_adaptation | 1.25521220 |
| 72 | MP0003137_abnormal_impulse_conducting | 1.25233812 |
| 73 | MP0003186_abnormal_redox_activity | 1.24836505 |
| 74 | MP0006292_abnormal_olfactory_placode | 1.23710529 |
| 75 | MP0005535_abnormal_body_temperature | 1.22716374 |
| 76 | MP0000372_irregular_coat_pigmentation | 1.18373595 |
| 77 | MP0008789_abnormal_olfactory_epithelium | 1.18234759 |
| 78 | MP0005174_abnormal_tail_pigmentation | 1.18047812 |
| 79 | MP0001188_hyperpigmentation | 1.17844491 |
| 80 | MP0005551_abnormal_eye_electrophysiolog | 1.17380294 |
| 81 | MP0003111_abnormal_nucleus_morphology | 1.16721724 |
| 82 | MP0005409_darkened_coat_color | 1.16202527 |
| 83 | MP0002163_abnormal_gland_morphology | 1.12351904 |
| 84 | MP0002229_neurodegeneration | 1.12319454 |
| 85 | MP0002184_abnormal_innervation | 1.11419720 |
| 86 | MP0000371_diluted_coat_color | 1.10722402 |
| 87 | MP0002332_abnormal_exercise_endurance | 1.10333755 |
| 88 | MP0003077_abnormal_cell_cycle | 1.07156356 |
| 89 | MP0001502_abnormal_circadian_rhythm | 1.05218171 |
| 90 | MP0001727_abnormal_embryo_implantation | 1.05189740 |
| 91 | MP0002822_catalepsy | 1.04054839 |
| 92 | MP0002557_abnormal_social/conspecific_i | 1.02523127 |
| 93 | MP0000778_abnormal_nervous_system | 1.01813090 |
| 94 | MP0005670_abnormal_white_adipose | 1.00898393 |
| 95 | MP0002066_abnormal_motor_capabilities/c | 1.00099575 |
| 96 | MP0003122_maternal_imprinting | 0.98908109 |
| 97 | MP0003329_amyloid_beta_deposits | 0.97147532 |
| 98 | MP0003634_abnormal_glial_cell | 0.96843483 |
| 99 | MP0008007_abnormal_cellular_replicative | 0.94880602 |
| 100 | MP0002972_abnormal_cardiac_muscle | 0.94568785 |
| 101 | MP0001963_abnormal_hearing_physiology | 0.94276540 |
| 102 | MP0005330_cardiomyopathy | 0.93938292 |
| 103 | MP0005646_abnormal_pituitary_gland | 0.93877890 |
| 104 | MP0005389_reproductive_system_phenotype | 0.93438207 |
| 105 | MP0000647_abnormal_sebaceous_gland | 0.93162836 |
| 106 | MP0000516_abnormal_urinary_system | 0.92442547 |
| 107 | MP0005367_renal/urinary_system_phenotyp | 0.92442547 |
| 108 | MP0003690_abnormal_glial_cell | 0.92056576 |
| 109 | MP0000358_abnormal_cell_content/ | 0.89760797 |
| 110 | MP0002882_abnormal_neuron_morphology | 0.88171484 |
| 111 | MP0000230_abnormal_systemic_arterial | 0.88088034 |
| 112 | MP0002752_abnormal_somatic_nervous | 0.87314339 |
| 113 | MP0004084_abnormal_cardiac_muscle | 0.87309837 |
| 114 | MP0005253_abnormal_eye_physiology | 0.86899200 |
| 115 | MP0004484_altered_response_of | 0.86668079 |
| 116 | MP0005636_abnormal_mineral_homeostasis | 0.86573235 |
| 117 | MP0001664_abnormal_digestion | 0.86363502 |
| 118 | MP0008872_abnormal_physiological_respon | 0.85403307 |
| 119 | MP0005377_hearing/vestibular/ear_phenot | 0.84097632 |
| 120 | MP0003878_abnormal_ear_physiology | 0.84097632 |
| 121 | MP0004085_abnormal_heartbeat | 0.83405369 |
| 122 | MP0004147_increased_porphyrin_level | 0.83250242 |
| 123 | MP0003121_genomic_imprinting | 0.83062567 |
| 124 | MP0000747_muscle_weakness | 0.82899805 |
| 125 | MP0008877_abnormal_DNA_methylation | 0.82407966 |
| 126 | MP0009697_abnormal_copulation | 0.80227754 |
| 127 | MP0005085_abnormal_gallbladder_physiolo | 0.79274494 |
| 128 | MP0003787_abnormal_imprinting | 0.78742706 |
| 129 | MP0005620_abnormal_muscle_contractility | 0.78316112 |
| 130 | MP0004019_abnormal_vitamin_homeostasis | 0.77291513 |
| 131 | MP0002909_abnormal_adrenal_gland | 0.76901555 |
| 132 | MP0005332_abnormal_amino_acid | 0.76617572 |
| 133 | MP0005408_hypopigmentation | 0.76208632 |
| 134 | MP0000013_abnormal_adipose_tissue | 0.75596752 |
| 135 | MP0002090_abnormal_vision | 0.75363142 |
| 136 | MP0000026_abnormal_inner_ear | 0.75208821 |
| 137 | MP0005084_abnormal_gallbladder_morpholo | 0.74458271 |
| 138 | MP0005266_abnormal_metabolism | 0.73837884 |
| 139 | MP0000631_abnormal_neuroendocrine_gland | 0.73767556 |
| 140 | MP0002106_abnormal_muscle_physiology | 0.72358811 |
| 141 | MP0002751_abnormal_autonomic_nervous | 0.72286394 |
| 142 | MP0002234_abnormal_pharynx_morphology | 0.72150185 |
| 143 | MP0001186_pigmentation_phenotype | 0.71989145 |
| 144 | MP0001293_anophthalmia | 0.71967691 |
| 145 | MP0005360_urolithiasis | 0.71349559 |
| 146 | MP0005410_abnormal_fertilization | 0.70789098 |
| 147 | MP0000639_abnormal_adrenal_gland | 0.69711687 |
| 148 | MP0003567_abnormal_fetal_cardiomyocyte | 0.68497274 |
| 149 | MP0001919_abnormal_reproductive_system | 0.68473957 |
| 150 | MP0002075_abnormal_coat/hair_pigmentati | 0.68340541 |
| 151 | MP0002210_abnormal_sex_determination | 0.68330674 |
| 152 | MP0005365_abnormal_bile_salt | 0.67748704 |
| 153 | MP0005391_vision/eye_phenotype | 0.65065753 |
| 154 | MP0002653_abnormal_ependyma_morphology | 0.63594624 |
| 155 | MP0005187_abnormal_penis_morphology | 0.63078034 |
| 156 | MP0001929_abnormal_gametogenesis | 0.62027392 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 7.92083316 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 7.29236466 |
| 3 | Progressive macrocephaly (HP:0004481) | 6.69028447 |
| 4 | Mitochondrial inheritance (HP:0001427) | 6.64421652 |
| 5 | Acute encephalopathy (HP:0006846) | 6.59500392 |
| 6 | Increased CSF lactate (HP:0002490) | 5.67935738 |
| 7 | Hepatocellular necrosis (HP:0001404) | 5.67833213 |
| 8 | Hepatic necrosis (HP:0002605) | 5.14874358 |
| 9 | Cerebral edema (HP:0002181) | 4.76019681 |
| 10 | Increased hepatocellular lipid droplets (HP:0006565) | 4.65737755 |
| 11 | Lipid accumulation in hepatocytes (HP:0006561) | 4.30281798 |
| 12 | Myokymia (HP:0002411) | 4.26763302 |
| 13 | Leukodystrophy (HP:0002415) | 4.22500560 |
| 14 | Renal Fanconi syndrome (HP:0001994) | 4.16804207 |
| 15 | Respiratory failure (HP:0002878) | 4.15364721 |
| 16 | Increased serum pyruvate (HP:0003542) | 4.14981919 |
| 17 | Abnormality of glycolysis (HP:0004366) | 4.14981919 |
| 18 | Optic disc pallor (HP:0000543) | 4.11252017 |
| 19 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.01097094 |
| 20 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.01097094 |
| 21 | 3-Methylglutaconic aciduria (HP:0003535) | 3.97912493 |
| 22 | Exercise intolerance (HP:0003546) | 3.92319845 |
| 23 | Lactic acidosis (HP:0003128) | 3.90159959 |
| 24 | Increased intramyocellular lipid droplets (HP:0012240) | 3.89566909 |
| 25 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.85032472 |
| 26 | Pheochromocytoma (HP:0002666) | 3.62284089 |
| 27 | Neuroendocrine neoplasm (HP:0100634) | 3.60297477 |
| 28 | Increased muscle lipid content (HP:0009058) | 3.46171441 |
| 29 | Increased serum lactate (HP:0002151) | 3.43226845 |
| 30 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.39172659 |
| 31 | Sensory axonal neuropathy (HP:0003390) | 3.06878699 |
| 32 | Type I transferrin isoform profile (HP:0003642) | 2.99740378 |
| 33 | Abnormality of alanine metabolism (HP:0010916) | 2.89675439 |
| 34 | Hyperalaninemia (HP:0003348) | 2.89675439 |
| 35 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.89675439 |
| 36 | Abnormality of renal resorption (HP:0011038) | 2.87328408 |
| 37 | Degeneration of anterior horn cells (HP:0002398) | 2.86095675 |
| 38 | Abnormality of the anterior horn cell (HP:0006802) | 2.86095675 |
| 39 | Exertional dyspnea (HP:0002875) | 2.84114928 |
| 40 | X-linked dominant inheritance (HP:0001423) | 2.79959244 |
| 41 | Myotonia (HP:0002486) | 2.68925168 |
| 42 | Hyperglycinemia (HP:0002154) | 2.68606481 |
| 43 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.67976384 |
| 44 | Hypoplasia of the fovea (HP:0007750) | 2.67976384 |
| 45 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.63527658 |
| 46 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.63527658 |
| 47 | Abnormal protein glycosylation (HP:0012346) | 2.63527658 |
| 48 | Abnormal glycosylation (HP:0012345) | 2.63527658 |
| 49 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.61978778 |
| 50 | Respiratory difficulties (HP:0002880) | 2.58638576 |
| 51 | CNS demyelination (HP:0007305) | 2.58328496 |
| 52 | Patchy hypopigmentation of hair (HP:0011365) | 2.53862668 |
| 53 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.51143150 |
| 54 | Lethargy (HP:0001254) | 2.49324628 |
| 55 | Emotional lability (HP:0000712) | 2.46310750 |
| 56 | Reduced antithrombin III activity (HP:0001976) | 2.42203240 |
| 57 | Abnormality of serum amino acid levels (HP:0003112) | 2.38025447 |
| 58 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.37503018 |
| 59 | Glycosuria (HP:0003076) | 2.35849513 |
| 60 | Abnormality of urine glucose concentration (HP:0011016) | 2.35849513 |
| 61 | Focal motor seizures (HP:0011153) | 2.35514361 |
| 62 | Abnormality of the fovea (HP:0000493) | 2.32455500 |
| 63 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.25884498 |
| 64 | Hypothermia (HP:0002045) | 2.25401387 |
| 65 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.24885783 |
| 66 | Conjunctival hamartoma (HP:0100780) | 2.22006788 |
| 67 | Hyperphosphaturia (HP:0003109) | 2.17773644 |
| 68 | Palpitations (HP:0001962) | 2.15551220 |
| 69 | Abnormality of methionine metabolism (HP:0010901) | 2.15246345 |
| 70 | Adrenal hypoplasia (HP:0000835) | 2.10879922 |
| 71 | Calf muscle hypertrophy (HP:0008981) | 2.09537464 |
| 72 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.07796151 |
| 73 | Cerebral hemorrhage (HP:0001342) | 2.07709492 |
| 74 | Medial flaring of the eyebrow (HP:0010747) | 2.05039880 |
| 75 | Parakeratosis (HP:0001036) | 2.04425980 |
| 76 | White forelock (HP:0002211) | 2.00285768 |
| 77 | Methylmalonic aciduria (HP:0012120) | 2.00138665 |
| 78 | Opisthotonus (HP:0002179) | 1.99266742 |
| 79 | Microvesicular hepatic steatosis (HP:0001414) | 1.99205422 |
| 80 | Abnormal number of erythroid precursors (HP:0012131) | 1.97841333 |
| 81 | Retinal dysplasia (HP:0007973) | 1.96928289 |
| 82 | Progressive microcephaly (HP:0000253) | 1.95166198 |
| 83 | Muscle stiffness (HP:0003552) | 1.94099399 |
| 84 | Methylmalonic acidemia (HP:0002912) | 1.93499537 |
| 85 | Anxiety (HP:0000739) | 1.90067941 |
| 86 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.89773083 |
| 87 | Molar tooth sign on MRI (HP:0002419) | 1.89547824 |
| 88 | Abnormality of midbrain morphology (HP:0002418) | 1.89547824 |
| 89 | Abnormal urine phosphate concentration (HP:0012599) | 1.87717387 |
| 90 | Vomiting (HP:0002013) | 1.87391569 |
| 91 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.86595327 |
| 92 | Abnormality of glycine metabolism (HP:0010895) | 1.86595327 |
| 93 | Congenital, generalized hypertrichosis (HP:0004540) | 1.85657841 |
| 94 | Macrocytic anemia (HP:0001972) | 1.85278730 |
| 95 | Dicarboxylic aciduria (HP:0003215) | 1.84908836 |
| 96 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84908836 |
| 97 | Hypoglycemic coma (HP:0001325) | 1.84382540 |
| 98 | Gait imbalance (HP:0002141) | 1.83696618 |
| 99 | Abnormal pupillary function (HP:0007686) | 1.83531073 |
| 100 | Hyperglycinuria (HP:0003108) | 1.81218015 |
| 101 | Blindness (HP:0000618) | 1.80347672 |
| 102 | Delayed CNS myelination (HP:0002188) | 1.79295345 |
| 103 | Neoplasm of the adrenal gland (HP:0100631) | 1.77856667 |
| 104 | Limb dystonia (HP:0002451) | 1.77260248 |
| 105 | Cerebral hypomyelination (HP:0006808) | 1.76652126 |
| 106 | Abnormal hair whorl (HP:0010721) | 1.76619454 |
| 107 | Congenital primary aphakia (HP:0007707) | 1.76219269 |
| 108 | Gliosis (HP:0002171) | 1.75058183 |
| 109 | Hypokinesia (HP:0002375) | 1.74645601 |
| 110 | Reticulocytopenia (HP:0001896) | 1.72859754 |
| 111 | Renal tubular dysfunction (HP:0000124) | 1.71457884 |
| 112 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.70979195 |
| 113 | Congenital stationary night blindness (HP:0007642) | 1.69519894 |
| 114 | Metabolic acidosis (HP:0001942) | 1.68977000 |
| 115 | Nephrogenic diabetes insipidus (HP:0009806) | 1.68081114 |
| 116 | Poor suck (HP:0002033) | 1.67819091 |
| 117 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.67413363 |
| 118 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.67413363 |
| 119 | Ragged-red muscle fibers (HP:0003200) | 1.67398641 |
| 120 | Pancreatic cysts (HP:0001737) | 1.66926030 |
| 121 | Large for gestational age (HP:0001520) | 1.66691126 |
| 122 | Hyperventilation (HP:0002883) | 1.65723782 |
| 123 | Microretrognathia (HP:0000308) | 1.65326420 |
| 124 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.64662858 |
| 125 | Spastic paraparesis (HP:0002313) | 1.64377068 |
| 126 | Atonic seizures (HP:0010819) | 1.64326547 |
| 127 | Median cleft lip (HP:0000161) | 1.62246772 |
| 128 | Ketoacidosis (HP:0001993) | 1.62149896 |
| 129 | Genital tract atresia (HP:0001827) | 1.61450406 |
| 130 | Hypoplastic left heart (HP:0004383) | 1.61153822 |
| 131 | Abnormality of magnesium homeostasis (HP:0004921) | 1.61063323 |
| 132 | Vaginal atresia (HP:0000148) | 1.60212575 |
| 133 | Absence seizures (HP:0002121) | 1.59674209 |
| 134 | Epileptic encephalopathy (HP:0200134) | 1.57840296 |
| 135 | Delusions (HP:0000746) | 1.55136881 |
| 136 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.55094820 |
| 137 | Neurofibrillary tangles (HP:0002185) | 1.54865987 |
| 138 | Sudden death (HP:0001699) | 1.53327773 |
| 139 | Progressive external ophthalmoplegia (HP:0000590) | 1.52651909 |
| 140 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.49723584 |
| 141 | Generalized aminoaciduria (HP:0002909) | 1.48607191 |
| 142 | Abnormality of placental membranes (HP:0011409) | 1.48158038 |
| 143 | Amniotic constriction ring (HP:0009775) | 1.48158038 |
| 144 | Dialeptic seizures (HP:0011146) | 1.47014123 |
| 145 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.44074376 |
| 146 | Athetosis (HP:0002305) | 1.43267964 |
| 147 | Progressive inability to walk (HP:0002505) | 1.42575152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ARAF | 3.58856537 |
| 2 | NME1 | 3.43379049 |
| 3 | NME2 | 3.32481953 |
| 4 | NEK1 | 3.21064952 |
| 5 | STK39 | 3.11948383 |
| 6 | VRK2 | 3.06592911 |
| 7 | STK16 | 2.96897978 |
| 8 | MAP3K12 | 2.83047693 |
| 9 | CASK | 2.73632691 |
| 10 | GRK5 | 2.69524295 |
| 11 | TRIM28 | 2.48506872 |
| 12 | OXSR1 | 2.37158228 |
| 13 | MYLK | 2.30004653 |
| 14 | LIMK1 | 2.28624902 |
| 15 | WEE1 | 2.13592088 |
| 16 | EIF2AK1 | 2.13087568 |
| 17 | MAP4K2 | 2.12088447 |
| 18 | MST4 | 2.08415858 |
| 19 | SRPK1 | 2.07948826 |
| 20 | MUSK | 2.02364767 |
| 21 | WNK4 | 1.96071515 |
| 22 | GRK7 | 1.92046663 |
| 23 | BCR | 1.82243847 |
| 24 | BMPR1B | 1.68934510 |
| 25 | CDK19 | 1.56373162 |
| 26 | PBK | 1.56309184 |
| 27 | ZAK | 1.51817015 |
| 28 | VRK1 | 1.50093727 |
| 29 | PIM2 | 1.49737378 |
| 30 | ERBB3 | 1.45516757 |
| 31 | TNIK | 1.45096945 |
| 32 | OBSCN | 1.44340112 |
| 33 | PLK3 | 1.40124628 |
| 34 | UHMK1 | 1.39816119 |
| 35 | PLK4 | 1.39646281 |
| 36 | BRAF | 1.38765282 |
| 37 | PHKG2 | 1.35913731 |
| 38 | PHKG1 | 1.35913731 |
| 39 | FRK | 1.34461414 |
| 40 | MAPKAPK5 | 1.33503499 |
| 41 | NTRK3 | 1.30426192 |
| 42 | MAP2K7 | 1.27426845 |
| 43 | BCKDK | 1.25775084 |
| 44 | CSNK1A1L | 1.25546222 |
| 45 | MAPK13 | 1.24930636 |
| 46 | ADRBK2 | 1.22846219 |
| 47 | PNCK | 1.19155061 |
| 48 | CDC7 | 1.17615254 |
| 49 | PLK1 | 1.13456965 |
| 50 | NUAK1 | 1.13340572 |
| 51 | ADRBK1 | 1.13199969 |
| 52 | CAMK2B | 1.12707941 |
| 53 | PLK2 | 1.10490228 |
| 54 | CAMK2D | 1.07837096 |
| 55 | LMTK2 | 1.05774056 |
| 56 | CAMK2A | 1.00277577 |
| 57 | DYRK2 | 0.99828676 |
| 58 | MARK1 | 0.99729577 |
| 59 | PKN1 | 0.98389050 |
| 60 | TTK | 0.97127962 |
| 61 | GRK1 | 0.97057853 |
| 62 | CAMK2G | 0.94461118 |
| 63 | CSNK1G3 | 0.93303891 |
| 64 | BMPR2 | 0.89270547 |
| 65 | DAPK1 | 0.89240630 |
| 66 | ILK | 0.87846959 |
| 67 | MINK1 | 0.85914123 |
| 68 | BUB1 | 0.85422604 |
| 69 | AURKB | 0.79742139 |
| 70 | WNK3 | 0.79731170 |
| 71 | ROCK2 | 0.79135158 |
| 72 | PRKCE | 0.78842867 |
| 73 | CDK14 | 0.77886487 |
| 74 | EPHA4 | 0.77828360 |
| 75 | MAPKAPK3 | 0.77672826 |
| 76 | TESK1 | 0.77001590 |
| 77 | TESK2 | 0.76110690 |
| 78 | PAK4 | 0.75671976 |
| 79 | BRSK1 | 0.75100853 |
| 80 | ABL2 | 0.73960496 |
| 81 | SCYL2 | 0.73119986 |
| 82 | PRKACA | 0.71749219 |
| 83 | MAP3K4 | 0.71029146 |
| 84 | TLK1 | 0.70657977 |
| 85 | PRKCI | 0.69259922 |
| 86 | CDK8 | 0.68740268 |
| 87 | FER | 0.67410007 |
| 88 | DAPK3 | 0.66497921 |
| 89 | PINK1 | 0.66239746 |
| 90 | EIF2AK3 | 0.65081761 |
| 91 | ATR | 0.64550057 |
| 92 | KDR | 0.64213038 |
| 93 | TSSK6 | 0.63404074 |
| 94 | CDK18 | 0.63044298 |
| 95 | MAPK15 | 0.62768593 |
| 96 | CDK15 | 0.61025947 |
| 97 | PDK4 | 0.60562934 |
| 98 | PDK3 | 0.60562934 |
| 99 | PRKCG | 0.59832626 |
| 100 | INSRR | 0.58868619 |
| 101 | CDK5 | 0.56901032 |
| 102 | EIF2AK2 | 0.56596336 |
| 103 | KSR2 | 0.55821981 |
| 104 | CDK11A | 0.54540761 |
| 105 | CSNK1G1 | 0.53947572 |
| 106 | MAP3K9 | 0.52479097 |
| 107 | MOS | 0.50749911 |
| 108 | CSNK1G2 | 0.49772745 |
| 109 | CSNK1A1 | 0.48812114 |
| 110 | MKNK1 | 0.48027906 |
| 111 | MAP3K2 | 0.47236662 |
| 112 | NEK6 | 0.46680661 |
| 113 | AURKA | 0.44397244 |
| 114 | CHEK2 | 0.44229183 |
| 115 | TNK2 | 0.44010098 |
| 116 | PIK3CA | 0.43963022 |
| 117 | ERBB4 | 0.43755560 |
| 118 | PAK3 | 0.43628246 |
| 119 | ACVR1B | 0.42384318 |
| 120 | SGK494 | 0.42004011 |
| 121 | SGK223 | 0.42004011 |
| 122 | BRSK2 | 0.40532517 |
| 123 | PDK2 | 0.39873513 |
| 124 | AKT2 | 0.39046270 |
| 125 | RAF1 | 0.38244656 |
| 126 | EPHA2 | 0.37872832 |
| 127 | MKNK2 | 0.37590009 |
| 128 | STK24 | 0.37192674 |
| 129 | RPS6KA5 | 0.37111290 |
| 130 | NTRK1 | 0.36586713 |
| 131 | MAPK4 | 0.36065062 |
| 132 | RPS6KA4 | 0.35767565 |
| 133 | CCNB1 | 0.35739397 |
| 134 | IRAK1 | 0.35494796 |
| 135 | PAK1 | 0.35237856 |
| 136 | CSNK2A1 | 0.34929711 |
| 137 | NTRK2 | 0.34618134 |
| 138 | PRKG1 | 0.34387604 |
| 139 | MAP2K2 | 0.33920533 |
| 140 | CSNK2A2 | 0.33842032 |
| 141 | PRKCA | 0.33790505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 6.79737249 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 5.88506213 |
| 3 | Alzheimers disease_Homo sapiens_hsa05010 | 4.43462883 |
| 4 | Huntingtons disease_Homo sapiens_hsa05016 | 4.05609541 |
| 5 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 3.66408653 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 3.29103046 |
| 7 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.19084398 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.59557117 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.58409563 |
| 10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.27788038 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.22979213 |
| 12 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.21489402 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.91963401 |
| 14 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.88298123 |
| 15 | Mismatch repair_Homo sapiens_hsa03430 | 1.84874403 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.80614207 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 1.80169206 |
| 18 | DNA replication_Homo sapiens_hsa03030 | 1.78093980 |
| 19 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.61352392 |
| 20 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50379841 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.44381783 |
| 22 | RNA polymerase_Homo sapiens_hsa03020 | 1.42097142 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40575762 |
| 24 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.34278522 |
| 25 | Base excision repair_Homo sapiens_hsa03410 | 1.29117651 |
| 26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.29099172 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.28345190 |
| 28 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.22378407 |
| 29 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.20443733 |
| 30 | Nicotine addiction_Homo sapiens_hsa05033 | 1.15438699 |
| 31 | Spliceosome_Homo sapiens_hsa03040 | 1.11425034 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.10675527 |
| 33 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.09603455 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.09343690 |
| 35 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.08098571 |
| 36 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.02780840 |
| 37 | RNA degradation_Homo sapiens_hsa03018 | 1.02061172 |
| 38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.01856228 |
| 39 | RNA transport_Homo sapiens_hsa03013 | 0.95976069 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.95721179 |
| 41 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.95442209 |
| 42 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94951638 |
| 43 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.94058163 |
| 44 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.92181871 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 0.82739851 |
| 46 | GABAergic synapse_Homo sapiens_hsa04727 | 0.82299070 |
| 47 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.82213310 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.81332540 |
| 49 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.81094033 |
| 50 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.80481139 |
| 51 | Peroxisome_Homo sapiens_hsa04146 | 0.80207882 |
| 52 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.79232118 |
| 53 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.77846940 |
| 54 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.77531965 |
| 55 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76058011 |
| 56 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.75243032 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72990109 |
| 58 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.72103524 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71504631 |
| 60 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.68294713 |
| 61 | Taste transduction_Homo sapiens_hsa04742 | 0.65851318 |
| 62 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.65632252 |
| 63 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.65300167 |
| 64 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.63685222 |
| 65 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.63301534 |
| 66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62244934 |
| 67 | Morphine addiction_Homo sapiens_hsa05032 | 0.59483209 |
| 68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59088537 |
| 69 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.57562356 |
| 70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55560203 |
| 71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.54815187 |
| 72 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53901095 |
| 73 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.53199559 |
| 74 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.53120486 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52716710 |
| 76 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.52030991 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.51947001 |
| 78 | Retinol metabolism_Homo sapiens_hsa00830 | 0.51610150 |
| 79 | Phototransduction_Homo sapiens_hsa04744 | 0.50962508 |
| 80 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.50948776 |
| 81 | Purine metabolism_Homo sapiens_hsa00230 | 0.50242924 |
| 82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49949411 |
| 83 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.49542353 |
| 84 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.48086795 |
| 85 | Histidine metabolism_Homo sapiens_hsa00340 | 0.46266790 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46242707 |
| 87 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.45598174 |
| 88 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43706274 |
| 89 | Circadian entrainment_Homo sapiens_hsa04713 | 0.43380306 |
| 90 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.42273456 |
| 91 | Phagosome_Homo sapiens_hsa04145 | 0.41647263 |
| 92 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40546016 |
| 93 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.38376771 |
| 94 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.37843918 |
| 95 | Cell cycle_Homo sapiens_hsa04110 | 0.37661196 |
| 96 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.37552810 |
| 97 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.36182012 |
| 98 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.35307567 |
| 99 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33876164 |
| 100 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.32583233 |
| 101 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32450518 |
| 102 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.31051632 |
| 103 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.30247067 |
| 104 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.30148256 |
| 105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29555242 |
| 106 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.28447766 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28192713 |
| 108 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.26177006 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.26044495 |
| 110 | Olfactory transduction_Homo sapiens_hsa04740 | 0.25719816 |
| 111 | Renin secretion_Homo sapiens_hsa04924 | 0.25434239 |
| 112 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.25310123 |
| 113 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.25048286 |
| 114 | Long-term depression_Homo sapiens_hsa04730 | 0.24228702 |
| 115 | Salivary secretion_Homo sapiens_hsa04970 | 0.23432822 |
| 116 | Insulin secretion_Homo sapiens_hsa04911 | 0.22194035 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.21641743 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20387748 |
| 119 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.20367848 |
| 120 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.19991365 |
| 121 | Cocaine addiction_Homo sapiens_hsa05030 | 0.19776760 |
| 122 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.16915789 |
| 123 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.16914106 |
| 124 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.13878988 |
| 125 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.13815644 |
| 126 | Mineral absorption_Homo sapiens_hsa04978 | 0.12830288 |
| 127 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.10098566 |
| 128 | Alcoholism_Homo sapiens_hsa05034 | 0.10054006 |
| 129 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.10033830 |
| 130 | Basal transcription factors_Homo sapiens_hsa03022 | 0.09542226 |
| 131 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.08672840 |
| 132 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.08096030 |
| 133 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.07383147 |
| 134 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.07353738 |
| 135 | Long-term potentiation_Homo sapiens_hsa04720 | 0.07302682 |
| 136 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.07196902 |
| 137 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.07172803 |

